CD4 and breast carcinoma: 3.6. Evaluation of the Effect of hBM-MSC-cm on the Capability of MDA-MB-231 and BT-474 Breast Cancer Cells to Generate Regulatory T Lymphocytes (CD4+CD25+FoxP3+)